Phase 3 results from the European clinical trial of the Palforzia peanut OIT treatment show that desensitization to the allergenic… Read more »
Author: Gwen Smith
FARE Makes Case for Standardized Food Allergy ‘May Contain’ Label
The nonprofit Food Allergy Research and Education (FARE) recently published a three-part research report that looks closely at the food… Read more »
DBV Cuts Costs Awaiting FDA; Unveils More Peanut Patch Results
With much of the Food and Drug Administration’s staff working on the coronavirus pandemic, the timeline for reviews of some… Read more »
FDA’s Relaxed Label Rules: Updates Fail to Silence Allergy Concerns
The Food and Drug Administration recently updated its guidance on a temporary food labeling policy that has been causing widespread… Read more »
Palforzia OIT Study Sees Maturing of Immune System Over Time
A study found encouraging results for those considering the first FDA-approved peanut allergy immunotherapy. It reveals that clinical trial participants… Read more »
Food Allergy and Asthma: the Burden on the Black Community
Updated January 2022 – Discussions about systemic racial bias have gained prominence in the past few years, and health care… Read more »
COVID-19 and Food in the Class: What Allergy Families Need to Know
As families emerge from the COVID-19 lockdown, masks at the ready, many are thinking ahead to autumn – and the… Read more »
Kaléo Announces Relaunch in Canada of Allerject Auto-Injector
The compact Allerject epinephrine auto-injector will relaunch across the Canada as of May 19, the pharmaceutical maker Kaléo has announced.… Read more »
Experts Revise Anaphylaxis Emergency Plan for COVID-19
The standard recommendation for anyone experiencing anaphylaxis is: administer epinephrine promptly in the reaction, and call 9-1-1 to have an… Read more »
Allergists See Palforzia Starting New Era of Food Allergy Therapy
Allergists that Allergic Living contacted are excited about the FDA’s approval of the first-ever therapy for a food allergy. They… Read more »